 Praveer Singh
Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 13 | 2026 | 181 | 3.240 |
Why?
| | Artificial Intelligence | 13 | 2025 | 381 | 1.550 |
Why?
| | Retina | 3 | 2026 | 330 | 0.840 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2026 | 420 | 0.640 |
Why?
| | Algorithms | 5 | 2026 | 1851 | 0.640 |
Why?
| | Image Processing, Computer-Assisted | 4 | 2026 | 783 | 0.570 |
Why?
| | Gestational Age | 10 | 2026 | 990 | 0.500 |
Why?
| | Ophthalmology | 3 | 2023 | 120 | 0.490 |
Why?
| | Machine Learning | 4 | 2026 | 587 | 0.450 |
Why?
| | Infant, Newborn | 14 | 2026 | 6465 | 0.440 |
Why?
| | Geographic Atrophy | 2 | 2026 | 97 | 0.420 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1957 | 0.420 |
Why?
| | Infant, Premature | 4 | 2026 | 620 | 0.400 |
Why?
| | ROC Curve | 5 | 2026 | 618 | 0.350 |
Why?
| | Glaucoma | 2 | 2025 | 251 | 0.340 |
Why?
| | Fundus Oculi | 4 | 2026 | 89 | 0.320 |
Why?
| | Neonatal Screening | 3 | 2026 | 179 | 0.290 |
Why?
| | Telemedicine | 3 | 2023 | 967 | 0.280 |
Why?
| | Optical Imaging | 1 | 2026 | 62 | 0.220 |
Why?
| | Optic Disk | 1 | 2025 | 53 | 0.210 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 270 | 0.190 |
Why?
| | Privacy | 1 | 2023 | 41 | 0.190 |
Why?
| | Retinal Artery | 1 | 2021 | 17 | 0.170 |
Why?
| | Retinal Vein | 1 | 2021 | 14 | 0.170 |
Why?
| | Racism | 1 | 2023 | 147 | 0.160 |
Why?
| | Crowdsourcing | 1 | 2020 | 18 | 0.160 |
Why?
| | Photography | 1 | 2021 | 119 | 0.160 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2021 | 92 | 0.160 |
Why?
| | Sensitivity and Specificity | 5 | 2023 | 2000 | 0.160 |
Why?
| | Humans | 24 | 2026 | 145783 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1752 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 883 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 992 | 0.130 |
Why?
| | Reproducibility of Results | 5 | 2025 | 3418 | 0.130 |
Why?
| | Risk Factors | 3 | 2026 | 10919 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2933 | 0.120 |
Why?
| | Diagnostic Imaging | 3 | 2022 | 337 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2024 | 1331 | 0.110 |
Why?
| | Birth Weight | 3 | 2023 | 517 | 0.110 |
Why?
| | Ophthalmoscopy | 2 | 2023 | 38 | 0.090 |
Why?
| | Infant | 5 | 2024 | 10091 | 0.090 |
Why?
| | Area Under Curve | 2 | 2021 | 332 | 0.080 |
Why?
| | Male | 7 | 2026 | 73010 | 0.080 |
Why?
| | Female | 7 | 2026 | 79045 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2025 | 17330 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2393 | 0.060 |
Why?
| | Uncertainty | 1 | 2026 | 146 | 0.060 |
Why?
| | Ethers, Cyclic | 1 | 2023 | 11 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2026 | 289 | 0.050 |
Why?
| | Benzofurans | 1 | 2023 | 26 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2024 | 287 | 0.050 |
Why?
| | Smartphone | 1 | 2023 | 107 | 0.040 |
Why?
| | Radiologists | 1 | 2022 | 61 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5925 | 0.040 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2024 | 198 | 0.040 |
Why?
| | Radiography, Thoracic | 1 | 2022 | 172 | 0.040 |
Why?
| | Nepal | 1 | 2021 | 32 | 0.040 |
Why?
| | Hospital Units | 1 | 2021 | 32 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2021 | 118 | 0.040 |
Why?
| | Breast Density | 1 | 2020 | 8 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 251 | 0.040 |
Why?
| | India | 1 | 2021 | 213 | 0.040 |
Why?
| | Reference Standards | 1 | 2021 | 177 | 0.040 |
Why?
| | North America | 1 | 2021 | 304 | 0.040 |
Why?
| | Radiography | 1 | 2022 | 853 | 0.040 |
Why?
| | Adult | 4 | 2024 | 40881 | 0.040 |
Why?
| | Risk | 1 | 2021 | 923 | 0.040 |
Why?
| | Mammography | 1 | 2020 | 166 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 849 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2139 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2123 | 0.030 |
Why?
| | Oxygen | 1 | 2021 | 981 | 0.030 |
Why?
| | Prognosis | 1 | 2024 | 4330 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2024 | 5428 | 0.030 |
Why?
| | Aged | 2 | 2025 | 26217 | 0.030 |
Why?
| | Child | 2 | 2024 | 22740 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 36309 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3916 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 8078 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4116 | 0.020 |
Why?
|
|
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|